Who
Marc Banjak
Chief Legal Officer
Company insider
Files Form 4 as: Chief Legal Officer, iBio.
In numbers
- Trades disclosed
- 9
- Buys
- 2
- Sells
- 0
- Bought
- $71K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 Jan 2025
- Last trade
- 26 Mar 2026
- Last filed
- 27 Mar 2026
Companies traded
Activity over time
1 Jan 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Mar 2026filed 27 Mar 2026 | IBIO iBioBiotechnology | SEC FORM 4 Bought | $21K12,500 at $1.64 | filing |
| 26 Mar 2026filed 27 Mar 2026 | IBIO iBioBiotechnology | SEC FORM 4 Bought | $2,5241,434 at $1.76 | filing |
| 26 Mar 2026filed 27 Mar 2026 | IBIO iBioBiotechnology | SEC FORM 4 Bought | $21K12,500 at $1.64 | filing |
| 26 Mar 2026filed 27 Mar 2026 | IBIO iBioBiotechnology | SEC FORM 4 Bought | $2,5241,434 at $1.76 | filing |
| 28 Jan 2026filed 30 Jan 2026 | IBIO iBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —146,000 at $0.00 | filing |
| 28 Jan 2026filed 30 Jan 2026 | IBIO iBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —146,000 at $0.00 | filing |
| 20 Oct 2025filed 22 Oct 2025 | IBIO iBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 21 Feb 2025filed 24 Feb 2025 | IBIO iBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —71,000 at $0.00 | filing |
| 10 Jan 2025filed 13 Jan 2025 | IBIO iBioBiotechnology | SEC FORM 4 Bought | $25K9,191 at $2.72 | filing |
News
Head to Head Comparison: Myriad Genetics (NASDAQ:MYGN) & iBio (NASDAQ:IBIO)IBIO · themarketsdaily.com · 19 Oct 2026
0 headlines in the last 90 days name Marc Banjak; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.